Security Snapshot

Immunocore Holdings plc - Ordinary Shares, nominal value 0.002 GBP per share (IMCR) Institutional Ownership

CUSIP: 45258D105

13F Institutional Holders and Ownership History from Q1 2021 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

50

Shares (Excl. Options)

8.25MFull value: 8,251,717 · shares · 30 Sep 2026

Price

$30.29

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Ordinary Shares, nominal value 0.002 GBP per share
Symbol
IMCR on Nasdaq
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
8,251,717
Latest holder snapshot 5 signals
Total 13F value
$250,090,691
Portfolio coverage rank
0%
Share change
-154,942
Value change
-$4,966,232
Number of holders
50
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
52,308,519
SEC-reported price per share
$27.82
Insider filing price
$27.82
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • IMCR - Immunocore Holdings plc - Ordinary Shares, nominal value 0.002 GBP per share is tracked under CUSIP 45258D105.
  • 50 institutions reported positions in Q3 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 135 to 50 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $1.65BFull value: $1,653,706,045 · USD · 30 Jun 2026
    to
    $250.09MFull value: $250,090,691 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 50 institutions filings for Q3 2026.

Open SEC evidence

Security key

45258D105

13F reference period

Q3 2026

13F holders

50

13D/G owners

9

CIK / CUSIP context first

Open Q3 2026 holders IMCR full holder history Immunocore Holdings plc SEC filings Immunocore Holdings plc company facts Immunocore Holdings plc insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
IMCR
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 12% +14% $190,355,150 +$26,410,388 5,959,773 +16% Wellington Management Group LLP 30 Jun 2026
Jallal Bahija 8.2% $135,513,072 4,493,139 Jallal Bahija 31 Dec 2024
PRIMECAP MANAGEMENT CO/CA/ 7.5% +44% $130,443,852 +$38,165,393 3,772,234 +41% PRIMECAP MANAGEMENT CO/CA/ 30 Jun 2025
Bellevue Group AG 5.6% $101,607,853 2,796,803 Bellevue Group AG 20 Aug 2025
Point72 Asset Management, L.P. 5.2% $75,671,596 2,720,043 Point72 Asset Management, L.P. 06 Nov 2026
TANG CAPITAL MANAGEMENT LLC 5.2% $94,662,520 2,605,608 TANG CAPITAL MANAGEMENT, LLC 17 Oct 2025
T. Rowe Price Investment Management, Inc. 3.7% -38% $60,417,704 -$36,740,710 1,891,600 -38% T. Rowe Price Investment Management, Inc. 31 Mar 2026
Vestal Point Capital, LP 3.5% -33% $57,492,000 -$30,881,764 1,800,000 -35% Vestal Point Capital, LP 30 Jun 2026
FMR LLC 3.6% -58% $52,613,094 -$77,853,387 1,736,979 -60% FMR LLC 30 Sep 2026
As of 30 Sep 2026, 50 institutional investors reported holding
8.25MFull value: 8,251,717 · shares · 30 Sep 2026
shares of Immunocore Holdings plc - Ordinary Shares, nominal value 0.002 GBP per share (IMCR). This represents 16% of the company’s total
52.31MFull value: 52,308,519 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
15%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PRIMECAP MANAGEMENT CO/CA/ 7% 3,635,850 -0.07% 0.07% $110,129,896
MARSHALL WACE, LLP 1.2% 614,728 +4% 0.02% $18,620,111
Hudson Bay Capital Management LP 1% 535,000 -9.3% 0.09% $16,205,150
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.76% 399,458 -1.9% 0% $12,099,583
Jones Hill Capital LP 0.73% 384,278 -25% 2% $11,639,781
Candriam S.C.A. 0.7% 366,492 -1.8% 0.05% $11,141,602
Qube Research & Technologies Ltd 0.63% 330,543 +48% 0.01% $10,012,147
RENAISSANCE TECHNOLOGIES LLC 0.51% 267,200 +161% 0.01% $8,093,488
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.41% 214,293 +60% 0% $6,490,935
MORGAN STANLEY 0.39% 205,885 +9.6% 0% $6,236,257
Jump Financial, LLC 0.23% 118,383 -10% 0.03% $3,585,821
Fulcrum Asset Management LLP 0.22% 116,000 -75% 0.17% $3,578,600
STATE STREET CORP 0.2% 106,410 +8.3% 0% $3,223,159
Y-Intercept (Hong Kong) Ltd 0.19% 97,515 -23% 0.07% $2,953,729
HighVista Strategies LLC 0.14% 75,840 +76% 0.6% $2,297,194
ALPS ADVISORS INC 0.13% 68,246 +33% 0.01% $2,067,171
TD ASSET MANAGEMENT INC 0.12% 63,358 -39% 0% $1,954,594
Quadrature Capital Ltd 0.12% 62,637 -15% 0.01% $1,897,275
BNP PARIBAS FINANCIAL MARKETS 0.11% 58,968 0% $1,786,141
Virtus Investment Advisers, LLC 0.11% 58,201 +45% 0.39% $1,762,908
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 0.1% 52,481 +33% 0.01% $1,589,649
GEODE CAPITAL MANAGEMENT, LLC 0.1% 51,840 +13% 0% $1,570,233
Eagle Health Investments LP 0.09% 46,300 0% 0.24% $1,402,427
Tidal Investments LLC 0.09% 45,820 +49% 0% $1,387,888
Hennion & Walsh Asset Management, Inc. 0.09% 44,878 -7.1% 0.04% $1,359,355

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
23
Headline period
Q3 2026
Rows shown
1-23 of 23
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 8,251,717 $250,090,691 -$4,966,232 $30.29 50
2026 Q2 52,107,162 $1,653,706,045 -$5,980,190 $31.75 135
2026 Q1 52,393,743 $1,579,585,800 +$22,621,289 $30.15 142
2025 Q4 51,535,356 $1,787,298,986 +$61,545,552 $34.71 149
2025 Q3 49,181,489 $1,786,701,511 +$50,897,730 $36.33 132
2025 Q2 47,759,431 $1,498,675,257 +$17,984,702 $31.38 132
2025 Q1 47,287,653 $1,402,998,400 +$60,274,148 $29.67 115
2024 Q4 45,410,647 $1,339,563,608 -$4,915,367 $29.50 114
2024 Q3 45,295,985 $1,411,075,539 +$61,107,953 $31.13 129
2024 Q2 43,068,701 $1,459,854,294 -$99,787,937 $33.89 135
2024 Q1 41,233,666 $2,679,814,816 +$238,809,048 $65.00 149
2023 Q4 37,514,062 $2,563,043,022 +$32,940,976 $68.32 133
2023 Q3 36,945,020 $1,917,423,501 +$85,494,203 $51.90 125
2023 Q2 35,306,138 $2,115,733,529 +$164,020,008 $59.96 118
2023 Q1 32,689,414 $1,614,615,481 +$118,700,415 $49.44 108
2022 Q4 30,264,419 $1,727,211,273 +$217,928,825 $57.07 103
2022 Q3 26,369,515 $1,237,624,033 +$261,557,875 $46.94 83
2022 Q2 21,039,614 $784,510,369 +$56,584,747 $37.31 66
2022 Q1 19,740,280 $590,138,252 +$57,754,634 $29.90 57
2021 Q4 17,133,052 $586,618,000 +$22,048,655 $34.24 45
2021 Q3 16,654,128 $617,381,000 +$83,084,443 $37.07 46
2021 Q2 13,805,464 $538,109,000 +$10,183,214 $39.05 41
2021 Q1 14,110,965 $597,836,000 +$597,835,003 $42.57 41
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .